Literature DB >> 26093791

Unexpected high photothemal conversion efficiency of gold nanospheres upon grafting with two-photon luminescent ruthenium(II) complexes: A way towards cancer therapy?

Pingyu Zhang1, Jinquan Wang1, Huaiyi Huang1, Bole Yu1, Kangqiang Qiu1, Juanjuan Huang1, Shutao Wang2, Lei Jiang3, Gilles Gasser4, Liangnian Ji1, Hui Chao5.   

Abstract

The design and development of functional hybrid nanomaterials is currently a topic of great interest in biomedicine. Herein we investigated the grafting of Ru(II) polypyridyl complexes onto gold nanospheres (Ru@AuNPs) to improve the particles' near infrared (NIR) absorption, and ultimately allow for application in photothermal cancer therapy. As demonstrated in this article, these ruthenium(II) complexes could indeed significantly enhance gold nanospheres' two-photon luminescence (PTL) intensity and photothermal therapy (PTT) efficiency. The best dual functional nanoparticles of this study were successfully used for real-time luminescent imaging-guided PTT in live cancer cells. Furthermore, in vivo tumor ablation was achieved with excellent treatment efficacy under a diode laser (808 nm) irradiation at the power density of 0.8 W/cm(2) for 5 min. This study demonstrates that the coupling of inert Ru(II) polypyridyl complexes to gold nanospheres allows for the enhancement of two-photon luminescence and for efficient photothermal effect.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gold nanospheres; Photothermal; Ru(II) complex; Two-photon luminescence

Mesh:

Substances:

Year:  2015        PMID: 26093791     DOI: 10.1016/j.biomaterials.2015.06.012

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

Review 1.  Critical discussion of the applications of metal complexes for 2-photon photodynamic therapy.

Authors:  Johannes Karges; Hui Chao; Gilles Gasser
Journal:  J Biol Inorg Chem       Date:  2020-11-04       Impact factor: 3.358

2.  Amino-Functionalized Mesoporous Silica Nanoparticle-Encapsulated Octahedral Organoruthenium Complex as an Efficient Platform for Combatting Cancer.

Authors:  Marina Martínez-Carmona; Quy P Ho; Jérémy Morand; Ana García; Enrique Ortega; Luiza C S Erthal; Eduardo Ruiz-Hernandez; M Dolores Santana; José Ruiz; Maria Vallet-Regí; Yurii K Gun'ko
Journal:  Inorg Chem       Date:  2020-07-06       Impact factor: 5.165

3.  Influence of carbon nanotubes and graphene nanosheets on photothermal effect of hydroxyapatite.

Authors:  Gururaj M Neelgund; Aderemi R Oki
Journal:  J Colloid Interface Sci       Date:  2016-07-29       Impact factor: 8.128

Review 4.  The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.

Authors:  Leli Zeng; Pranav Gupta; Yanglu Chen; Enju Wang; Liangnian Ji; Hui Chao; Zhe-Sheng Chen
Journal:  Chem Soc Rev       Date:  2017-10-02       Impact factor: 54.564

5.  RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety.

Authors:  Yu Lu; Zidong Peng; Di Zhu; Yijiang Jia; Ayijiang Taledaohan; Yuanming Li; Jiawang Liu; Yanming Wang; Yuji Wang
Journal:  Int J Nanomedicine       Date:  2021-08-16

6.  Laser Synthesized Core-Satellite Fe-Au Nanoparticles for Multimodal In Vivo Imaging and In Vitro Photothermal Therapy.

Authors:  Olga Yu Griaznova; Iaroslav B Belyaev; Anna S Sogomonyan; Ivan V Zelepukin; Gleb V Tikhonowski; Anton A Popov; Aleksei S Komlev; Petr I Nikitin; Dmitry A Gorin; Andrei V Kabashin; Sergey M Deyev
Journal:  Pharmaceutics       Date:  2022-05-05       Impact factor: 6.525

Review 7.  Near Infrared Fluorescence Imaging in Nano-Therapeutics and Photo-Thermal Evaluation.

Authors:  Mukti Vats; Sumit Kumar Mishra; Mahdieh Shojaei Baghini; Deepak S Chauhan; Rohit Srivastava; Abhijit De
Journal:  Int J Mol Sci       Date:  2017-04-28       Impact factor: 5.923

8.  In vivo theranostics with near-infrared-emitting carbon dots-highly efficient photothermal therapy based on passive targeting after intravenous administration.

Authors:  Xin Bao; Ye Yuan; Jingqin Chen; Bohan Zhang; Di Li; Ding Zhou; Pengtao Jing; Guiying Xu; Yingli Wang; Kateřina Holá; Dezhen Shen; Changfeng Wu; Liang Song; Chengbo Liu; Radek Zbořil; Songnan Qu
Journal:  Light Sci Appl       Date:  2018-11-21       Impact factor: 17.782

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.